Carlos Eduardo Stecca

Formação complementar

Idiomas

Áreas de atuação

Produções bibliográficas

• STECCA, CARLOS ; ABDELJALIL, OSAMA ; SRIDHAR, SRIKALA S. . Metastatic Urothelial Cancer: a rapidly changing treatment landscape. Therapeutic Advances in Medical Oncology , v. 13, p. 175883592110473, 2021.

• STECCA, CARLOS E. ; ALT, MARIE ; JIANG, DI MARIA ; CHUNG, PETER ; CROOK, JUANITA M. ; KULKARNI, GIRISH S. ; SRIDHAR, SRIKALA S. . Recent Advances in the Management of Penile Cancer: A Contemporary Review of the Literature. Oncology And Therapy , v. 9, p. 21-39, 2021.

• ALT, MARIE ; STECCA, CARLOS ; TOBIN, SWANEE ; JIANG, DI MARIA ; SRIDHAR, SRIKALA S. . Enfortumab Vedotin in urothelial cancer. THERAPEUTIC ADVANCES IN UROLOGY , v. 12, p. 175628722098019, 2020.

• DE OLIVEIRA, RIVADÁVIO A. M. ; DA SILVA, TASSIARA ; PIOVESANA, MARIANA MIYASAKI ; STECCA, CARLOS EDUARDO ; LOPES, GEORGE A. ; LIUTTI, VITOR TEIXEIRA . Advanced Esophageal Neoplasm with Subcutaneous Metastasis. CASE REPORTS IN ONCOLOGICAL MEDICINE (PRINT) , v. 2019, p. 1-3, 2019.

• DA COSTA, ALEXANDRE A. B. A. ; COSTA, FELIPE D?ALMEIDA ; ARAÚJO, DANIEL VILARIM ; CAMANDAROBA, MARCOS PEDRO GUEDES ; DE JESUS, VICTOR HUGO FONSECA ; OLIVEIRA, AUDREY ; ALVES, ANA CAROLINE FONSECA ; STECCA, CARLOS ; MACHADO, LARISSA ; DE OLIVEIRA, ANDREA CRUZ FERAZ ; DE OLIVEIRA, THIAGO BUENO ; NICOLAU, ULISSES RIBALDO ; DE LIMA, VLADMIR CLÁUDIO CORDEIRO . The roles of PTEN, cMET, and p16 in resistance to cetuximab in head and neck squamous cell carcinoma. MEDICAL ONCOLOGY , v. 36, p. 8, 2019.

• DA COSTA, ALEXANDRE A. B. A. ; DO CANTO, LUISA M. ; LARSEN, SIMON JONAS ; RIBEIRO, ADRIANA REGINA GONÇALVES ; STECCA, CARLOS EDUARDO ; PETERSEN, ANNABETH HGH ; AAGAARD, MADS M. ; DE BROT, LOUISE ; BAUMBACH, JAN ; BAIOCCHI, GLAUCO ; ACHATZ, MARIA ISABEL ; ROGATTO, SILVIA REGINA . Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes. BMC CANCER , v. 19, p. 8, 2019.

• alt m ; STECCA, CARLOS ; Kabadi S ; Kazeem, B ; sridhar ss . Identification of characteristics associated with long-term survival in patients with metastatic urothelial carcinoma (mUC) who received durvalumab (D) with or without tremelimumab (T) in clinical studies.. In: 2021 Genitourinary Cancers Symposium, 2021, San Francisco. American Society of Clinical Oncology -ASCO, 2021.

• STECCA, CARLOS ; Jiang D ; alt m ; Elliot M ; Fallah-rad N ; Michelis G ; sridhar ss . Impact of the COVID-19 pandemic on the wellbeing of international fellows training in hematology/oncology at the Princess Margaret Cancer Centre (PMCC).. In: 2021 ASCO Annual Meeting, 2021, Chicago. American Society of Clinical Oncology -ASCO, 2021.

• Alqaisi, H ; Veitch Z ; STECCA, CARLOS ; kaiser J ; A.NORTH, S. ; summani s ; ALIMOHAMED, N. S. ; SRIDHAR, SRIKALA S. . The prognostic impact of bone metastasis in urothelial carcinoma treated with first-line platinum-based chemotherapy.. In: 2021 Genitourinary Cancers Symposium, 2021, San Francisco. American Society of Clinical Oncology -ASCO, 2021.

• summani s ; Veitch Z ; Alqaisi, H ; STECCA, CARLOS ; A.NORTH, S. ; kaiser J ; SRIDHAR, SRIKALA S. ; ALIMOHAMED, N. S. . Trends over time in survival in patients with urothelial carcinoma in the real-world: A multicenter analysis.. In: 2021 Genitourinary Cancers Symposium, 2021, San Francisco. American Society of Clinical Oncology -ASCO, 2021.

• STECCA, CARLOS ; Jiang D ; Veitch Z ; ALIMOHAMED, N. S. ; HOTTE, S. ; WOOD, L. ; SRIDHAR, SRIKALA S. . Evaluation of Trends in the Treatment of Metastatic Hormone Sensitive Prostate Cancer (mHSPC) across Canada during the COVID-19 pandemic. In: Canadian Urology Association -CUA, 2021, Virtual. Canadian Urology Association -CUA, 2021.

• COSTA, A. A. B. A. ; Ribeiro A ; MANTOAN, H. ; STECCA, CARLOS ; SANTOS, E. S. ; Lima J.P ; Oliveira A ; COTRIM, D. P. ; GRAPP, L. V. ; GUIMARAES, A. P. ; Baiocchi G . Interval between last neoadjuvant chemotherapy and surgery and between surgery and first adjuvant chemotherapy in ovarian cancer patients.. In: 2018 ASCO Annual Meeting, 2018, Chicago. American Society of Clinical Oncology -ASCO, 2018.

• COSTA, A. A. B. A. ; Salvadori M ; Valadares C ; STECCA, CARLOS ; Baiocchi G ; Achatz, M . Homologous recombination deficiency and platinum rechallenge in platinum-resistant ovarian cancer patients.. In: 2017 ASCO Annual Meeting, 2017, Chicago. American Society of Clinical Oncology -ASCO, 2017.

• COSTA, A. A. B. A. ; COSTA, F. D. ; OLIVEIRA, A. C. F. ; STECCA, CARLOS ; Oliveira A ; ALVES, A. C. F. ; CAMANDAROBA, M. P. G. ; ARAUJO, D. V. ; MACHADO, L. ; LIMA, V. C. C. . PTEN and cetuximab resistance in head and neck squamous cell carcinoma (HNSCC).. In: 2017 ASCO Annual Meeting, 2017, Chicago. American Society of Clinical Oncology -ASCO, 2017.

• STECCA, CARLOS . A phase II study of Lurbinectedin in patients with metastatic small cell carcinoma of genitourinary tract, unfit for or who have progression on a platinum-based chemotherapy. 2021. (Apresentação de Trabalho/Conferência ou palestra).

• STECCA, CARLOS . ASCO/ESMO updates on Bladder Cancer. 2020. (Apresentação de Trabalho/Simpósio).

Projetos de pesquisa

• 2020 - Atual

  feasibly of integrating epigenomic and genomic liquid biopsy biomarkers, Descrição: Hold?em for Life Fellowship Program Grant. , Situação: Em andamento; Natureza: Pesquisa. , Integrantes: Carlos Eduardo Stecca - Integrante / SRIDHAR, SRIKALA S. - Coordenador.

Prêmios